Limited availability
until July 18, 2023.
You will be redirected to our secure system.
When you need on-site attention, we’re not just here to help, we’re there to help—right by your side.
Individual courses are remarkably effective. But sometimes when you have a specific need, it helps to have expert guidance right in the room with you and your team.
In that case, we’re happy to design a custom training for your entire team, whether online—or on-site.
Learn moreRemember – at checkout you can choose to take this course On-demand. We offer a 10% group discount when you register 2 of more attendees (up to 10). Contact us for larger groups.
No drug substance or drug product is acceptable without a satisfactory stability profile. Yet, protein drug substances and drug products offer unique challenges when it comes to stability. From storage to handling, to testing, proteins often require thinking creatively to achieve an acceptable stability program.
This accredited 12-hour intensive course provides comprehensive and up-to-date knowledge of developing and executing compliant and effective stability programs for protein and peptide biopharmaceuticals and biologics. The course covers both US FDA and EU EMA regulatory and technical expectations and activities to fulfill those expectations, with the biotechnology guidelines of the International Council for Harmonization (ICH) receiving special attention.
The approach of the course is practical as well as theoretical so that attendees will be able to plan, accomplish and review stability studies and programs. Attendees will have the opportunity to apply what they have learned during a workshop in which participants join the instructor in planning model stability programs for relevant product types.
Can’t Make the LIVE Course dates?
You can register now for the on demand! Simply select the On Demand option when registering and we will automatically send you access to the recorded version for you to view for 30 days. On Demand will be available within 2 weeks after the live offering.
PLEASE NOTE: Since this training is highly interactive, you must have a webcam on your computer equipped with a microphone and speakers/headset in order to fully participate.
This course is designed to serve the needs of professionals working on Innovator and Biosimilar Protein and Peptide stability during development, regulatory filing, and for post-marketing studies. Because of its comprehensive content, this course will be valuable to personnel in:
– Stability Departments
– Research and Development
– QA and QC
– Regulatory Affairs
– Production
Professionals who are involved in planning, conducting, reviewing, supervising, or managing protein formulations, manufacturing, and stability testing activities to determine shelf lives and retest dates of pharmaceutical proteins and peptides would benefit greatly from this training.
Dr. Pardeep K. Gupta
Professor of Pharmaceutics, Philadelphia College of Pharmacy, University of The Sciences in Philadelphia (USciences)
Dr. Pardeep K. Gupta is a Professor of Pharmaceutics in Philadelphia College of Pharmacy at the University of The Sciences in Philadelphia (USciences). He received his B. Pharm. and M. Pharm. (pharmaceutical chemistry) degrees from India. He also received a M.S. degree in medicinal chemistry from USciences and his Ph.D. in pharmaceutics from University of Wisconsin. His research interests include delivery of proteins and peptides and study of the interaction of drugs with biomembranes. He has published several articles and has authored several book chapters. His teaching responsibilities include courses in solubility, controlled drug delivery and drug stability at the graduate level. He is on the editorial board of Remington: The Science and Practice of Pharmacy, and is the editor of Pharmaceutical Chemistry and Pharmaceutical Testing, Analysis and Control sections of the book.